Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Homozygosity mapping guided next generation sequencing to identify the causative genetic variation in inherited retinal degenerative diseases.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 9808008 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-232X (Electronic) Linking ISSN: 14345161 NLM ISO Abbreviation: J Hum Genet Subsets: MEDLINE
- Publication Information:
Publication: 2009- : London : Nature Pub. Group
Original Publication: Tokyo : Springer-Verlag, c1998-
- Subject Terms:
- Abstract:
Inherited retinal degeneration (IRD) are a group of genetically heterogeneous disease of which retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are the most common and severe type. In our study we had taken three unrelated South Indian consanguineous IRD families. Homozygosity mapping was done using Affymetrix 250K Nsp1 GeneChip in each of LCA, Cone-Rod dystrophy (CRD) and autosomal recessive RP (arRP) families followed by targeted re-sequencing by next generation sequencing (NGS) on Illumina MiSeq. Known candidate genes ranging from 1-8 in numbers within the homozygous blocks were identified by homozygosity mapping and targeted NGS revealed the causative mutations; RDH12 c.832A>C, ABCA4 c.1462G>T, CDHR1c.1384_1392delCTCCTGGACinsG, in the LCA, CRD and arRP families, respectively. The identified mutations were validated by Sanger sequencing, segregation in the families and their absence in 200 control chromosomes. Homozygosity mapping guided targeted NGS, especially when more numbers of known candidate genes within the homozygous blocks are observed is a comprehensive method for mutation identification. Molecular data from a larger retinal degenerative disease cohort would reveal the spectrum and prevalence of mutations and genes in Indian population. Molecular diagnosis also aids in genetic counseling, offering carrier and prenatal testing to family members.
- References:
World J Clin Cases. 2015 Feb 16;3(2):112-24. (PMID: 25685757)
Sci Rep. 2015 Sep 09;5:13902. (PMID: 26350383)
Am J Hum Genet. 2006 May;78(5):889-96. (PMID: 16642444)
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5690-8. (PMID: 18055821)
Hum Mol Genet. 2005 Dec 15;14(24):3865-75. (PMID: 16269441)
Eur J Hum Genet. 2013 Mar;21(3):274-80. (PMID: 22968130)
J Hum Genet. 2016 Jun;61(6):515-22. (PMID: 26911350)
Nat Methods. 2014 Apr;11(4):361-2. (PMID: 24681721)
Bioinformatics. 2005 Jul 15;21(14):3176-8. (PMID: 15879453)
Ophthalmic Genet. 2000 Sep;21(3):135-50. (PMID: 11035546)
Mol Vis. 2012;18:1165-74. (PMID: 22605927)
Mol Vis. 2014 Apr 26;20:553-60. (PMID: 24791140)
PLoS One. 2010 Nov 15;5(11):e13996. (PMID: 21085596)
Nucleic Acids Res. 2011 Sep 1;39(17):e118. (PMID: 21727090)
Nat Methods. 2010 Apr;7(4):248-9. (PMID: 20354512)
Mol Vis. 2008 Mar 10;14:481-6. (PMID: 18334959)
Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):1883-94. (PMID: 22395892)
PLoS One. 2015 Jul 06;10(7):e0131679. (PMID: 26147992)
Hum Mol Genet. 2002 May 15;11(10):1219-27. (PMID: 12015282)
Ophthalmic Genet. 2003 Jun;24(2):75-80. (PMID: 12789571)
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):985-90. (PMID: 17325136)
PLoS Genet. 2009 Jan;5(1):e1000353. (PMID: 19165332)
Nat Protoc. 2009;4(7):1073-81. (PMID: 19561590)
Am J Hum Genet. 2000 Oct;67(4):960-6. (PMID: 10958761)
Bioinformatics. 2009 Nov 1;25(21):2744-50. (PMID: 19734154)
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1065-8. (PMID: 19011012)
Prog Retin Eye Res. 2008 Jul;27(4):391-419. (PMID: 18632300)
Eur J Hum Genet. 2014 Jan;22(1):99-104. (PMID: 23591405)
Hum Mol Genet. 2009 Mar 1;18(5):931-41. (PMID: 19074458)
Nat Genet. 1997 Oct;17(2):194-7. (PMID: 9326941)
- Publication Date:
Date Created: 20160708 Date Completed: 20170406 Latest Revision: 20181113
- Publication Date:
20221213
- Accession Number:
10.1038/jhg.2016.83
- Accession Number:
27383656
No Comments.